Target intelligence / Profile preview

Glutamate-ammonia ligase pseudogene 3 (GLULP3)

Target
GLULP3
Molecular classification
Other, Pseudogene
01

Overview

Glutamate-ammonia ligase pseudogene 3 (GLULP3) is a genomic DNA sequence in humans that represents a nonfunctional copy (pseudogene) of the gene encoding glutamate-ammonia ligase (glutamine synthetase). Unlike the active enzyme, pseudogenes such as GLULP3 lack the ability to encode a functional protein due to disabling mutations, deletions, or rearrangements. Pseudogenes may have regulatory functions at the RNA level but generally do not serve as drug targets or have major biological roles. There is no evidence that GLULP3 encodes an active receptor, transporter, or enzyme, nor is it linked to any diseases, drug action, or clinical biomarker use[3]. GLULP3 should not be confused with the functional **glutamate-ammonia ligase (GLUL)** enzyme, which does play significant biological roles in nitrogen metabolism. The presence of "pseudogene" in its name indicates that this specific entry is non-functional with respect to its protein-coding potential[3].

Other names
GLUL pseudogene 3GLULP3
02

Mechanism of action

Not applicable; as a pseudogene, there is no mechanism of action for drugs.

03

Biological functions

None known; as a pseudogene, GLULP3 does not have direct biological function
04

Disease associations

None known; pseudogenes may be involved in genetic regulatory processes, but GLULP3 is not associated with disease roles
05

Safety considerations

None reported; pseudogenes like GLULP3 do not pose safety concerns or therapeutic challenges.
06

Interacting drugs

None. No drugs are known to interact with GLULP3 since it does not produce a functional molecule.
07

Biomarkers

None known; GLULP3 is not used as a biomarker for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Glutamate-ammonia ligase pseudogene 3 (GLULP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate-ammonia ligase pseudogene 3 (GLULP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call